Hepion Pharmaceuticals Inc. (HEPA) EPS growth this year is 65.60%: Get Prepared for Trading Lift Off
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) open the trading on June 10, 2021, with great promise as it jumped 15.31% to $2.26. During the day, the stock rose to $2.30 and sunk to $1.985 before settling in for the price of $1.96 at the close. Taking a more long-term approach, HEPA posted a 52-week range of $1.45-$4.83.
Meanwhile, its Annual Earning per share during the time was 64.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.60%. This publicly-traded company’s shares outstanding now amounts to $76.23 million, simultaneously with a float of $62.65 million. The organization now has a market capitalization sitting at $165.70 million. At the time of writing, stock’s 50-day Moving Average stood at $1.74, while the 200-day Moving Average is $2.34.
Hepion Pharmaceuticals Inc. (HEPA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Hepion Pharmaceuticals Inc.’s current insider ownership accounts for 0.10%, in contrast to 23.70% institutional ownership. According to the most recent insider trade that took place on Feb 18, this organization’s Chief Financial Officer bought 10,000 shares at the rate of 2.00, making the entire transaction reach 20,000 in total value, affecting insider ownership by 14,800. Preceding that transaction, on Feb 18, Company’s CEO and Director bought 20,000 for 2.00, making the whole transaction’s value amount to 40,000. This particular insider is now the holder of 45,259 in total.
Hepion Pharmaceuticals Inc. (HEPA) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 3/30/2021 suggests? It has posted -$0.12 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.2) by $0.08. This company achieved a return on equity of -71.79. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
Hepion Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 65.60% and is forecasted to reach -0.51 in the upcoming year.
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) Trading Performance Indicators
Let’s observe the current performance indicators for Hepion Pharmaceuticals Inc. (HEPA). It’s Quick Ratio in the last reported quarter now stands at 41.10. The Stock has managed to achieve an average true range (ATR) of 0.12.
In the same vein, HEPA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.68, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.51 at the market close of one year from today.
Technical Analysis of Hepion Pharmaceuticals Inc. (HEPA)
[Hepion Pharmaceuticals Inc., HEPA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 84.79% While, its Average True Range was 0.13.
Raw Stochastic average of Hepion Pharmaceuticals Inc. (HEPA) in the period of the previous 100 days is set at 46.82%, which indicates a major fall in contrast to 94.63% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 64.19% that was lower than 95.61% volatility it exhibited in the past 100-days period.